Rad51b activity and cell cycle regulation in response to DNA damage in breast cancer cell lines

Breast Cancer: Basic and Clinical Research

Volumn 8, Issue , 2014, Pages 135-144

  Lee, Phoebe S ^a   Fang, Jun ^a   Jessop, Lea ^a   Myers, Timothy ^a   Raj, Preethi ^a   Hu, Nan ^a   Wang, Chaoyu ^a   Taylor, Philip R ^a   Wang, Jianjun ^a   Khan, Javed ^a   Jasin, Maria ^b   Chanock, Stephen J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast cancer; DNA damage; Homologous recombination; RAD51B

Indexed keywords

CISPLATIN; HYDROXYUREA; MESYLIC ACID METHYL ESTER; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER CELL LINE; CANCER SUSCEPTIBILITY; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DIVISION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; G2 PHASE CELL CYCLE CHECKPOINT; GENE; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RAD51B GENE; RECOMBINATION REPAIR;

EID: 84907864264     PISSN: None     EISSN: 11782234     Source Type: Journal    
DOI: 10.4137/BCBCR.S17766     Document Type: Article

References (64)

1. Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet. 2001;27(3):247–254.
2. Pierce AJ, Stark JM, Araujo FD, Moynahan ME, Berwick M, Jasin M. Doublestrand breaks and tumorigenesis. Trends Cell Biol. 2001;11(11):S52–S59.
3. Holthausen JT, Wyman C, Kanaar R. Regulation of DNA strand exchange in homologous recombination. DNA Repair. 2010;9(12):1264–1272.
4. Baumann P, Benson FE, West SC. Human Rad51 protein promotes ATPdependent homologous pairing and strand transfer reactions in vitro. Cell. 1996; 87(4):757–766.
5. Baumann P, West SC. The human Rad51 protein: polarity of strand transfer and stimulation by hRP-A. EMBO J. 1997;16(17):5198–5206.
6. Albala JS, Thelen MP, Prange C, et al. Identification of a novel human RAD51 homolog, RAD51B. Genomics. 1997;46(3):476–479.
7. Rice MC, Smith ST, Bullrich F, Havre P, Kmiec EB. Isolation of human and mouse genes based on homology to REC2, a recombinational repair gene from the fungus Ustilago maydis. Proc Natl Acad Sci U S A. 1997;94(14): 7417–7422.
8. Cartwright R, Dunn AM, Simpson PJ, Tambini CE, Thacker J. Isolation of novel human and mouse genes of the recA/RAD51 recombination-repair gene family. Nucleic Acids Res. 1998;26(7):1653–1659.
9. Dosanjh MK, Collins DW, Fan W, et al. Isolation and characterization of RAD51C, a new human member of the RAD51 family of related genes. Nucleic Acids Res. 1998;26(5):1179–1184.
10. Pittman DL, Weinberg LR, Schimenti JC. Identification, characterization, and genetic mapping of Rad51d, a new mouse and human RAD51/RecA-related gene. Genomics. 1998;49(1):103–111.
11. Kawabata M, Saeki K. Multiple alternative transcripts of the human homologue of the mouse TRAD/R51H3/RAD51D gene, a member of the rec A/RAD51 gene family. Biochem Biophys Res Commun. 1999;257(1):156–162.
12. Liu N, Lamerdin JE, Tebbs RS, et al. XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA crosslinks and other damages. Mol Cell. 1998;1(6):783–793.
13. Cartwright R, Tambini CE, Simpson PJ, Thacker J. The XRCC2 DNA repair gene from human and mouse encodes a novel member of the recA/RAD51 family. Nucleic Acids Res. 1998;26(13):3084–3089.
14. Johnson RD, Liu N, Jasin M. Mammalian XRCC2 promotes the repair of DNA double-strand breaks by homologous recombination. Nature. 1999;401(6751): 397–399.
15. Tebbs RS, Zhao Y, Tucker JD, et al. Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc Natl Acad Sci U S A. 1995;92(14):6354–6358.
16. Masson JY, Tarsounas M., Stasiak AZ, et al. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev. 2001; 15(24):3296–3307.
17. Compton SA, Ozgur S, Griffith JD. Ring-shaped Rad51 paralog protein complexes bind Holliday junctions and replication forks as visualized by electron microscopy. J Biol Chem. 2010;285(18):13349–13356.
18. Sigurdsson S, Van Komen S, Bussen W, Schild D, Albala JS, Sung P. Mediator function of the human Rad51B-Rad51C complex in Rad51/RPA-catalyzed DNA strand exchange. Genes Dev. 2001;15(24):3308–3318.
19. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266(5182): 66–71.
20. Kobayashi H, Ohno S, Sasaki Y, Matsuura M. Hereditary breast and ovarian cancer susceptibility genes (review). Oncol Rep. 2013;30(3):1019–1029.
21. Foulkes WD, Shuen AY. In brief: BRCA1 and BRCA2. J Pathol. 2013;230(4): 347–349.
22. Akbari MR, Tonin P, Foulkes WD, Ghadirian P, Tischkowitz M, Narod SA. RAD51C germline mutations in breast and ovarian cancer patients. Breast Cancer Res. 2010;12(4):404.
23. Meindl A, Hellebrand H, Wiek C, et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet. 2010;42(5):410–414.
24. Somyajit K, Subramanya S, Nagaraju G. RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer. Carcinogenesis. 2010;31(12):2031–2038.
25. Loveday C, Turnbull C, Ramsay E, et al. Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat Genet. 2011;43(9):879–882.
26. Suwaki N, Klare K, Tarsounas M. RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumorigenesis. Semin Cell Dev Biol. 2011;22(8): 898–905.
27. Thomas G, Jacobs KB, Kraft P, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet. 2009;41(5):579–584.
28. Figueroa JD, Garcia-Closas M, Humphreys M, et al. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Um Mol Genet. 2011;20(23):4693–4706.
29. Stevens KN, Vachon CM, Lee AM, et al. Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res. 2011;71(19): 6240–6249.
30. Long J, Zhang B, Signorello LB, et al. Evaluating genome-wide association study-identified breast cancer risk variants in African-American women. PLoS One. 2013;8(4):e58350.
31. Vachon CM, Scott CG, Fasching PA, et al. Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2012; 21(7):1156–1166.
32. Orr N, Lemnrau A, Cooke R, et al. Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk. Nat Genet. 2012;44(11):1182–1184.
33. Jung S, Lee S, Lee J, et al. Protein expression pattern in response to ionizing radiation in MCF-7 human breast cancer cells. Oncol Lett. 2012;3(1):147–154.
34. Peng L, Rice MC, Kmiec EB. Analysis of the human RAD51L1 promoter region and its activation by UV light. Genomics. 1998;54(3):529–541.
35. Takata M, Sasaki MS, Sonoda E, et al. The Rad51 paralog Rad51B promotes homologous recombinational repair. Mol Cell Biol. 2000;20(17):6476–6482.
36. Date O, Katsura M, Ishida M, et al. Haploinsufficiency of RAD51B causes centrosome fragmentation and aneuploidy in human cells. Cancer Res. 2006;66(12): 6018–6024.
37. Havre PA, Rice MC, Noe M, Kmiec EB. The human REC2/RAD51B gene acts as a DNA damage sensor by inducing G1 delay and hypersensitivity to ultraviolet irradiation. Cancer Res. 1998;58(20):4733–4739.
38. Rodrigue A, Coulombe Y, Jacquet K, et al. The RAD51 paralogs ensure cellular protection against mitotic defects and aneuploidy. J Cell Sci. 2013;126(pt 1): 348–359.
39. Stordal B, Davey R. ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repair. Cancer Chemother Pharmacol. 2009;63(4):661–672.
40. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc. 2006;1(5):2315–2319.
41. Petit C, Sancar A. Nucleotide excision repair: from E. coli to man. Biochimie. 1999;81(1–2):15–25.
42. Pierce AJ, Johnson RD, Thompson LH, Jasin M. XRCC3 promotes homologydirected repair of DNA damage in mammalian cells. Genes Dev. 1999;13(20): 2633–2638.
43. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550.
44. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61–70.
45. Vandersickel V, Slabbert J, Thierens H, Vral A. Comparison of the colony formation and crystal violet cell proliferation assays to determine cellular radiosensitivity in a repair-deficient MCF10A cell line. Radiat Meas. 2011;46(1):72–75.
46. Chun J, Buechelmaier ES, Powell SN. Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway. Mol Cell Biol. 2013;33(2):387–395.
47. Dronkert ML, Kanaar R. Repair of DNA interstrand cross-links. Mutat Res. 2001;486(4):217–247.
48. Bianchi V, Pontis E, Reichard P. Changes of deoxyribonucleoside triphosphate pools induced by hydroxyurea and their relation to DNA synthesis. J Biol Chem. 1986;261(34):16037–16042.
49. Sabatinos SA. Recovering a stalled replication fork. Nat Educ. 2010;3(9):31.
50. Vig BK, Lewis R. Genetic toxicology of bleomycin. Mutat Res. 1978;55(2): 121–145.
51. Wyatt MD, Pittman DL. Methylating agents and DNA repair responses: methylated bases and sources of strand breaks. Chem Res Toxicol. 2006;19(12):1580–1594.
52. Lundin C, North M, Erixon K, et al. Methyl methanesulfonate (MMS) produces heat-labile DNA damage but no detectable in vivo DNA double-strand breaks. Nucleic Acids Res. 2005;33(12):3799–3811.
53. Hasselbach L, Haase S, Fischer D, Kolberg HC, Sturzbecher HW. Characterisation of the promoter region of the human DNA-repair gene Rad51. Eur J Gynaecol Oncol. 2005;26(6):589–598.
54. Arias-Lopez C, Lazaro-Trueba I, Kerr P, et al. p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene. EMBO Rep. 2006;7(2):219–224.
55. Henson SE, Tsai SC, Malone CS, et al. Pir51, a Rad51-interacting protein with high expression in aggressive lymphoma, controls mitomycin C sensitivity and prevents chromosomal breaks. Mutat Res. 2006;601(1–2):113–124.
56. Ko JC, Ciou SC, Cheng CM, et al. Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells. Carcinogenesis. 2008;29(7): 1448–1458.
57. Chen F, Nastasi A, Shen Z, Brenneman M, Crissman H, Chen DJ. Cell cycledependent protein expression of mammalian homologs of yeast DNA doublestrand break repair genes Rad51 and Rad52. Mutat Res. 1997;384(3):205–211.
58. Vispe S, Cazaux C, Lesca C, Defais M. Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucleic Acids Res. 1998;26(12):2859–2864.
59. Raderschall E, Bazarov A, Cao J, et al. Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis. J Cell Sci. 2002;115(pt 1):153–164.
60. Sorenson CM, Eastman A. Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells. Cancer Res. 1988;48(23):6703–6707.
61. Sorenson CM, Barry MA, Eastman A. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst. 1990;82(9):749–755.
62. Ma W, Westmoreland JW, Resnick MA. Homologous recombination rescues ssDNA gaps generated by nucleotide excision repair and reduced translesion DNA synthesis in yeast G2 cells. Proc Natl Acad Sci U S A. 2013;110(31): E2895–E2904.
63. Molinari M, Mercurio C, Dominguez J, Goubin F, Draetta GF. Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep. 2000;1(1):71–79.
64. Deng CX. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res. 2006;34(5):1416–1426.